Drug Information

General Information
Drug ID
DR00142
Drug Name
L-alanine
Synonyms
(2S)-2-Aminopropanoic acid; (C14)L-Alanine; (L)-Alanine; (S)-(+)-Alanine; (S)-2-Aminopropanoic acid; (S)-2-Aminopropionic acid; (S)-2-Aminopropionsaeure; (S)-Alanine; (S)-alpha-Aminopropionsaeure; 14C-L-Alanine; 2-Aminopropionic acid; A-Alanine; A-Aminopropionic acid; ALA; Alanina; Alanina [DCIT,Spanish]; Alanine; Alanine (USP); Alanine (VAN); Alanine [USAN:INN]; Alanine, L-(7CI,8CI); Alaninum; Alaninum [Latin]; Alpha-Alanine; Alpha-Aminopropionic acid; F4F207FF-8FF8-4789-99A1-147AE0A36673; H-Ala-OH; L-&alpha-alanine; L-(+)-Alanine; L-2-Aminopropanoic acid; L-2-Aminopropionic acid; L-2-Aminopropionsaeure; L-A-Aminopropionicacid; L-Alanin; L-Alanine (9CI); L-Alanine (JAN); L-Alanine, N-coco alkyl derivs.;Propanoic acid, 2-amino-, (S); L-Alanine, homopolymer; L-Alanine, labeled with carbon-14; L-Alanine, labeled with tritium; L-S-Aminopropionic acid; L-a-Alanine; L-a-Aminopropionic acid; L-alpha-Aminopropionic acid; L-alpha-alanine; LPG; Poly-DL-alanine; Poly-L-alanine; Polyalanine
Drug Type
Small molecular drug
Indication Dietary shortage [ICD11: 5B7Z] Approved [1]
Glioma [ICD11: 2A00.0] Approved [1]
Therapeutic Class
Dietary supplement
Structure
3D MOL 2D MOL
Formula
C3H7NO2
Canonical SMILES
CC(C(=O)O)N
InChI
InChI=1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)/t2-/m0/s1
InChIKey
QNAYBMKLOCPYGJ-REOHCLBHSA-N
CAS Number
CAS 56-41-7
Pharmaceutical Properties Molecular Weight 89.09 Topological Polar Surface Area 63.3
Heavy Atom Count 6 Rotatable Bond Count 1
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 3
XLogP
-3
PubChem CID
5950
PubChem SID
103059020 , 103059733 , 103182286 , 103827139 , 103914796 , 104234104 , 104310701 , 10527484 , 11113404 , 11528607 , 14710664 , 14720011 , 14747373 , 24845820 , 24890849 , 24891241 , 24891260 , 24901893 , 29224973 , 3131856 , 3343 , 46504866 , 46508779 , 49655376 , 56437668 , 57323073 , 57580857 , 585842 , 589753 , 627087 , 6436532 , 78123937 , 7847080 , 7885836 , 7888688 , 8144737 , 8153694 , 822335 , 841591 , 85164877 , 85230829 , 85239779 , 87350317 , 87561861 , 92297527 , 92719579 , 96100165 , 96100173 , 99224270 , 99246016
ChEBI ID
ChEBI:16977
TTD Drug ID
D09PUL
DT(s) Transporting This Drug ASCT1 Transporter Info Alanine/serine/cysteine/threonine transporter 1 Substrate [2]
LAT2 Transporter Info L-type amino acid transporter 2 Substrate [3]
SNAT1 Transporter Info Sodium-coupled neutral amino acid transporter 1 Substrate [4]
SNAT2 Transporter Info Sodium-coupled neutral amino acid transporter 2 Substrate [4]
SNAT3 Transporter Info Sodium-coupled neutral amino acid transporter 3 Substrate [4]
SNAT4 Transporter Info Sodium-coupled neutral amino acid transporter 4 Substrate [4]
SNAT5 Transporter Info Sodium-coupled neutral amino acid transporter 5 Substrate [4]
Drug-Transporter Activity Data
Drug-Transporter Activity Data ASCT1 Transporter Info Km = 194 microM Rat hippocampal astrocyte-ASCT1 [2]
References
1 L-alanine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 D-Serine Is a Substrate for Neutral Amino Acid Transporters ASCT1/SLC1A4 and ASCT2/SLC1A5, and Is Transported by Both Subtypes in Rat Hippocampal Astrocyte Cultures. PLoS One. 2016 Jun 7;11(6):e0156551.
3 The Transporter Classification Database (TCDB): recent advances. Nucleic Acids Res. 2016 Jan 4;44(D1):D372-9. (ID: 2.A.3.8.20)
4 Identification of SLC38A7 (SNAT7) protein as a glutamine transporter expressed in neurons. J Biol Chem. 2011 Jun 10;286(23):20500-11.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.